Asia Pacific IVD Market by Product Type

1
Asia-Pacific In vitro Diagnostics Market
Global Opportunity Analysis and Industry
Forecast, 2017-2023
Asia Pacific IVD Market
2

• In vitro diagnostics is a technique used to
  identify several diseases and health conditions
  in a controlled artificial environment.
• The wide scope of application in various
  biological and medical diagnostics industries
  offers a competitive edge to the IVD device and
  reagents manufacturers.
• Likewise, factors such as, increasing government
  initiatives, growing RD activities for advanced
  diagnostics techniques, improving healthcare
  infrastructure, and rising per capita healthcare
  expenditure largely drive the Asia Pacific IVD
  market growth.
• On the other hand, lack of harmonization in
  regulatory guidelines coupled with inadequate
  reimbursement policies and technological barriers
  are hindering the market growth.

Introduction
Asia Pacific IVD Market
3

• The Asia-Pacific IVD Market accounted for 13,680
  million in 2016, and is estimated to reach at
  19,888 million by 2023, growing at a CAGR of
  5.4 from 2017 to 2023.
• IVD are the medical diagnostic devices comprised
  of any reagent, calibrator, control material,
  kit, specimen receptacle, software, instrument,
  apparatus, equipment or system used alone or in
  combination with other diagnostic devices,
  specifically designed for in-vitro examination of
  specimens of human body.
• In 2015, the immune system disorder and
  infectious diseases application segments together
  held a dominant share, of around 50 of the
  Asia-Pacific IVD market. This is attributed to
  the growing incidence and prevalence of
  infectious diseases namely, HIV/AIDS and
  Hepatitis and immune systems disorders namely,
  diabetes, and immune deficiency.
• The Stand-alone laboratories and hospital end
  user segments dominated the market in 2015 owing
  to frequent and primary use of in vitro
  diagnostic techniques for the detection of
  several diseases and disorders.

Overview
Asia Pacific IVD Market
4

• Infectious diseases segment is expected to
  maintain its foothold in the Asia-Pacific IVD
  market.
• Cancer is projected to be the fastest growing
  application segment during the forecast period.
• In 2015, infectious diseases and immune
  system disorders collectively accounted for about
  half of the Asia-Pacific IVD indication market.
• Asia-Pacific IVD Instruments market is
  projected to witness the highest CAGR of 7.1
  during the forecast period.
• India is forecasted to be the fastest growing
  market, growing at a CAGR of 7.1 from 2016 to
  2022.
• In 2015, China and Japan collectively
  accounted for around two-third of the Asia
  Pacific IVD market revenue.

Key findings of the study
Asia Pacific IVD Market
5

Top Investment Pocket
Asia Pacific IVD Market
6

Asia-Pacific IVD Market Segmentation
Asia Pacific IVD Market
7
About Allied Market Research Allied Market
Research (AMR) is a full-service market research
and business-consulting wing of Allied Analytics
LLP based in Portland, Oregon. Allied Market
Research provides global enterprises as well as
medium and small businesses with unmatched
quality of "Market Research Reports" and
"Business Intelligence Solutions". AMR has a
targeted view to provide business insights and
consulting to assist its clients to make
strategic business decisions and achieve
sustainable growth in their respective market
domain. Contact Us Int'l
1-503-894-6022 Toll Free 1-800-792-5285 Fax
1-800-792-5285
Contact Allied Market Research
Asia Pacific IVD Market
8
 
Web Real-Time Communication Market
Thank You! For More Details
Visit us at
https//www.alliedmarketresearch.com/asia-pacific
-IVD-market
Follow Us On
Asia Pacific IVD Market